Literature DB >> 6349861

Immunoassay of human muscle enolase subunit in serum: a novel marker antigen for muscle diseases.

K Kato, Y Okagawa, F Suzuki, A Shimizu, K Mokuno, Y Takahashi.   

Abstract

A sandwich enzyme immunoassay method for measurement of beta subunit of muscle enolase in human serum was developed by use of purified antibodies to enolase beta subunit and beta-D-galactosidase from Escherichia coli as label. The assay was specific to the beta subunit with no cross-reaction with the alpha and gamma subunits of human enolase. The measurable range was from 10 pg to 10 ng per assay tube or 1 to 1000 ng/ml serum. Coefficients of variation within-run and between-run for the assay of serum beta subunit were less than 14%. Normal adult sera contained about 6 ng/ml of the beta subunit, and the levels were significantly elevated in sera of patients with muscular dystrophy and those with myocardial infarction. Serum levels of the beta subunit correlated well with those of creatine phosphokinase, but poorly with those of myoglobin in the same samples. The specific distribution of beta subunit in skeletal muscle and heart was confirmed by measuring the levels in various tissue extracts.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6349861     DOI: 10.1016/0009-8981(83)90354-6

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  9 in total

Review 1.  The structure, function and evolution of proteins that bind DNA and RNA.

Authors:  William H Hudson; Eric A Ortlund
Journal:  Nat Rev Mol Cell Biol       Date:  2014-10-01       Impact factor: 94.444

2.  Immunohistochemical demonstration of carbonic anhydrase III and muscle-specific enolase in paraffin-embedded human skeletal muscle sections.

Authors:  T Ibi; H Haimoto; H Nagura; K Sahashi; K Kato; K Mokuno; K Sugimura; Y Matsuoka
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

3.  Effects of chronic n-hexane exposure on nervous system-specific and muscle-specific proteins.

Authors:  J Huang; K Kato; E Shibata; K Sugimura; N Hisanaga; Y Ono; Y Takeuchi
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

4.  An investigation of beta enolase as a histological marker of rhabdomyosarcoma.

Authors:  J A Royds; S Variend; W R Timperley; C B Taylor
Journal:  J Clin Pathol       Date:  1984-08       Impact factor: 3.411

5.  Molecular cloning and the nucleotide sequence of cDNA to mRNA for non-neuronal enolase (alpha alpha enolase) of rat brain and liver.

Authors:  K Sakimura; E Kushiya; M Obinata; Y Takahashi
Journal:  Nucleic Acids Res       Date:  1985-06-25       Impact factor: 16.971

6.  Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase and enolase activity and isoenzymes in lung, colon and liver carcinomas.

Authors:  N Durany; J Joseph; E Campo; R Molina; J Carreras
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Serum beta-enolase in acute myocardial infarction.

Authors:  M Nomura; K Kato; A Nagasaka; Y Shiga; Y Miyagi; R Fukui; H Nakano; Y Abo; S Okajima; A Nakai
Journal:  Br Heart J       Date:  1987-07

Review 8.  α-Enolase, a multifunctional protein: its role on pathophysiological situations.

Authors:  Angels Díaz-Ramos; Anna Roig-Borrellas; Ana García-Melero; Roser López-Alemany
Journal:  J Biomed Biotechnol       Date:  2012-10-14

9.  Cytogenetic and cellular characteristics of a human embryonal rhabdomyosarcoma cell line, RMS-YM.

Authors:  K Kubo; T Naoe; K R Utsumi; Y Ishiguro; K Ueda; H Shiku; K Yamada
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.